Lifestyle Interventions in Weight Loss Programs for Community- Based Patients with Severe Mental Disorders: A Scoping Review

Lifestyle Interventions in Weight Loss Programs for Community- Based Patients with Severe Mental Disorders: A Scoping Review

Authors

  • Giulia Picardo Department of Prevention and Biomedicine, Tor Vergata University, Rome, Italy
  • Clara Donnoli Department of Prevention and Biomedicine, Tor Vergata University, Rome, Italy
  • Giuseppe Liotta Department of Prevention and Biomedicine, Tor Vergata University, Rome, Italy

Keywords:

Nutritional intervention; obesity; psychiatric disease; severe mental disorder; weight loss

Abstract

Background. Patients with psychiatric disorders face exacerbated physical health issues and reduced life expectancy, primarily due to premature cardiovascular diseases. The intricate relationship between lifestyle factors, illness, and psychotropic medications contributes to this phenomenon. The focus of this research is to evaluate weight management interventions for individuals with Severe Mental Disorders through a comprehensive scoping review, investigating the characteristics, types, modalities and topics of interventions to provide a useful tool for professionals who want to promote lifestyle interventions for people with Severe Mental Disorders.

Methods. Eligible articles were peer-reviewed studies that reported an intervention targeted to patients with Severe Mental Disorders and aimed at promoting health through nonpharmacological interventions (including but not limited to nutritional education, physical activity and exercise interventions).

Results. A total of 20 studies with a total of 3,886 participants were evaluated.The studies included patients with a weighted mean age of 44.37 (SD=4.72) and a mean Body Mass Index of 34.7 kg/m2 (SD=3.56). Varied interventions, mostly conducted in the US, showed promising weight reduction and cardiovascular risk management results among patients with psychiatric disorders. However, disparate methods used in the studies hindered the evaluation of outcomes. The studies, which yielded the most interesting results, included parallel cluster randomized controlled trials, which showed improvements in HDL cholesterol and metabolic indicators, (HR 0.085; 95% CI:0.007-0.16) using IMPACT therapy, and a pragmatic randomized controlled trial which reported that with the InShape intervention 51% of participants achieved clinically significant reduction in overall cardiovascular risk.

Conclusion. Such a synthesis of findings provides valuable insights for future research, emphasizing the need for standardized outcome measures and more extended, comprehensive interventions.

References

1. Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease a -non- systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014 Sep 26;5:137. doi: 10.3389/fpsyt.2014.00137. PMID: 25309466; PMCID: PMC4175996.

2. Liu NK, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry. 2017 Feb 26;16(1):30-40. doi: 10.1002/ wps.20384. PMID: 28127922; PMCID: PMC5269481.

3. World Health Organization (WHO). Management of Physical Health Conditions in Adults with Severe Mental Disorders. Geneva: World Health Organization; 2018.

4. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017 Jun 12;16(2):163-80. doi: 10.1002/wps.20420. PMID: 28498599; PMCID: PMC5428179.

5. Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, et al. A meta-analysis of cardiometabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry. 2013 Oct;12(3):24050. doi: 10.1002/wps.20069. PMID: 24096790; PMCID: PMC3799255.

6. Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009 Mar 27;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. PMID: 19178394.

7. Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, McColl L, McNiven J. Psychotic Disorders, Eating Habits, and Physical Activity: Who Is Ready for Lifestyle Changes? Psychiatric Services. 2007 Feb;58(2):233-9. doi: 10.1176/ ps.2007.58.2.233. PMID: 17287381.

8. Huang J, Hei GR, Yang Y, Liu CC, Xiao JM, Long YJ, et al.

Increased Appetite Plays a Key Role in Olanzapine-Induced

Weight Gain in First-Episode Schizophrenia Patients. Front Pharmacol. 2020 May 22;11:739. doi: 10.3389/ fphar.2020.00739. doi: 10.3389/fphar.2020.00878. PMID: 32528286; PMCID: PMC7256453.

9. Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D, et al. GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity. J Clin Endocrinol Metab. 2020 May 1;105(5):1552-63. doi: 10.1210/clinem/dgz140. PMID: 31665455; PMCID: PMC7105351.

10. Elman I, Borsook D, Lukas SE. Food Intake and Reward Mechanisms in Patients with Schizophrenia: Implications for Metabolic Disturbances and Treatment with SecondGeneration Antipsychotic Agents. Neuropsychopharmacology. 2006 Oct 15;31(10):2091-120. doi: 10.1038/ sj.npp.1301051. Epub 2006 Mar 15. PMID: 16541087.

11. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee. Epub 2013 Nov 12. PMID: 24222017; PMCID: PMC5819889.

12. Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, et al. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014 Jul 24;22(S2). https://doi.org/10.1002/oby.20821.

13. Jacka FN. Nutritional Psychiatry: Where to Next? EBioMedicine. 2017 Mar;17:24-9. doi: 10.1016/j. ebiom.2017.02.020. Epub 2017 Feb 21. PMID: 28242200; PMCID: PMC5360575.

14. Williamson DA, Bray GA, Ryan DH. Is 5% weight loss a satisfactory criterion to define clinically significant weight loss? Obesity (Silver Spring). 2015 Dec 2;23(12):231920. doi: 10.1002/oby.21358. Epub 2015 Nov 2. PMID: 26523739.

15. Ryan DH, Yockey SR. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. Curr Obes Rep. 2017 Jun 28;6(2):187-94. doi: 10.1007/s13679017-0262-y. PMID: 28455679; PMCID: PMC5497590.

16. Bailey-Davis L, Wood GC, Benotti P, Cook A, Dove J, Mowery J, et al. Impact of Sustained Weight Loss on Cardiometabolic Outcomes. Am J Cardiol. 2022 Jan;162:66-72. doi: 10.1016/j.amjcard.2021.09.018. Epub 2021 Oct 24. PMID: 34702552.

17. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes. Diabetes Care. 2011 Jul 1;34(7):1481-6. doi: 10.2337/dc10-2415. Epub 2011 May 18. PMID: 21593294; PMCID: PMC3120182.

18. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021

Mar 29;372:n71. doi: 10.1136/bmj.n71. PMID: 33782057; PMCID: PMC8005924.

19. Bartels SJ, Pratt SI, Aschbrenner KA, Barre LK, Jue K, Wolfe RS, et al. Clinically Significant Improved Fitness and Weight Loss Among Overweight Persons With Serious Mental Illness. Psychiatr Serv. 2013 Aug 1;64(8):729-36. doi: 10.1176/appi.ps.003622012. PMID: 23677386; PMCID: PMC5662189.

20. Brown C, Read H, Stanton M, Zeeb M, Jonikas JA, Cook JA. A Pilot Study of the Nutrition and Exercise for Wellness and Recovery (NEW-R): A Weight Loss Program for Individuals with Serious Mental Illnesses. Psychiatr Rehabil J. 2015 Dec 1;38(4):371-3. doi: 10.1037/prj0000177. PMID: 25844916.

21. Gaughran F, Stahl D, Ismail K, Greenwood K, Atakan Z, Gardner-Sood P, et al. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT). BMC Psychiatry. 2017 Dec 28;17(1):413. doi: 10.1186/s12888017-1571-0. PMID: 29284438; PMCID: PMC5745644.

22. Pratt SI, Brunette MF, Wolfe R, Scherer EA, Xie H, Bartels S, et al. Incentivizing healthy lifestyle behaviors to reduce cardiovascular risk in people with serious mental illness: An equipoise randomized controlled trial of the wellness incentives program. Contemp Clin Trials. 2019 Jun;81:1-10. doi: 10.1016/j.cct.2019.04.005. Epub 2019 Apr 13. PMID: 30991110.

23. Bartels SJ, Pratt SI, Aschbrenner KA, Barre LK, Naslund JA, Wolfe R, et al. Pragmatic Replication Trial of Health Promotion Coaching for Obesity in Serious Mental Illness and Maintenance of Outcomes. Am Psychiatry. 2015 Apr;172(4):344-52. doi: 10.1176/appi. ajp.2014.14030357. Epub 2014 Dec 12. PMID: 25827032; PMCID: PMC4537796.

24. Aschbrenner KA, Mueser KT, Naslund JA, Gorin AA, Kinney A, Daniels L, et al. Feasibility Study of Increasing Social Support to Enhance a Healthy Lifestyle Intervention for Individuals with Serious Mental Illness. J Soc Social Work Res. 2016 Summer;7(2):289-313. doi: 10.1086/686486. Epub 2016 May 3. PMID: 28168015; PMCID: PMC5291178.

25. Naslund JA, Aschbrenner KA, Scherer EA, Pratt SI, Bartels SJ. Health Promotion for Young Adults With Serious Mental Illness. Psychiatr Serv. 2017 Feb 1;68(2):137-43. doi: 10.1176/appi.ps.201600091. Epub 2016 Nov 1. PMID: 27799016; PMCID: PMC5425088.

26. Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a Psychosocial Weight Management Program for Individuals with Schizophrenia. J Beahv Health Serv Res. 2014 Jul;41(3):370-80. doi: 10.1007/s11414-012-9273-3. PMID: 22430566; PMCID: PMC3809160.

27. Provencher MD, Belanger ME, Shriqui C, Lachance I, Bonneville S. L’éducation thérapeutique du patient pour les clientèles psychiatriques présentant un surpoids: l’exemple du programme «Wellness» développé au Québec [Psychoeducation for overweight patients with psychiatric disorders: The Wellness program developed in Quebec].

Encephale. 2016 Jun;42(3):201-7. French. doi: 10.1016/j. encep.2016.01.006. Epub 2016 Feb 26. PMID: 26924000.

28. Temmingh H, Claassen A, van Zyl S, Carrara H, Dayakalashe NM, Myer L, et al. The Evaluation of a Telephonic Wellness Coaching Intervention for Weight Reduction and Wellness Improvement in a Community-Based Cohort of Persons With Serious Mental Illness. J Nerv Ment Dis. 2013 Nov;201(11):977-86. doi: 10.1097/ NMD.0000000000000036. PMID: 24177486.

29. Aschbrenner KA, Naslund JA, Shevenell M, Kinney E, Bartels SJ. A Pilot Study of a Peer-Group Lifestyle Intervention Enhanced With mHealth Technology and Social Media for Adults With Serious Mental Illness. J Nerv Ment Dis. 2016 Jun;204(6):483-6. doi: 10.1097/NMD.0000000000000530. PMID: 27233056; PMCID: PMC4887192.

30. Aschbrenner KA, Mueser KT, Naslund JA, Gorin AA, Zawacki SA, Pratt SI, et al. Facilitating Partner Support for Lifestyle Change Among Adults with Serious Mental Illness: A Feasibility Pilot Study. Community Ment Health J. 2017 May

7;53(4):394-404. doi: 10.1007/s10597-017-0100-4. Epub 2017 Feb 7. PMID: 28176207; PMCID: PMC5510867.

31. Knight M, Bolton P, Coakley C, Kopeski L, Slifka K. Nursing Care for Lifestyle Behavioral Change. Issues Ment Health Nurs. 2015 Jun;36(6):464-73. doi:

10.3109/01612840.2014.997845. PMID: 26241573.

32. Aschbrenner KA, Naslund JA, Barre LK, Mueser KT, Kinney A, Bartels SJ. Peer health coaching for overweight and obese individuals with serious mental illness: intervention development and initial feasibility study. Transl Behav Med. 2015 Sep 11;5(3):277-84. doi: 10.1007/s13142-015-0313-4. PMID: 26327933; PMCID: PMC4537456.

33. Mangurian C, Chaudhry S, Capitelli L, Amiel J, Rosario F, Jackson C, et al. Implementation of a Weight Loss Program for Latino Outpatients with Severe Mental Illness. Community Ment Health J. 2013 Apr;49(2):150-6. doi: 10.1007/ s10597-012-9506-1. Epub 2012 Mar 24. PMID: 22447345.

34. Bartels SJ, Aschbrenner KA, Pratt SI, Naslund JA, Scherer EA, Zubkoff L, et al. Implementation of a Lifestyle Intervention for People With Serious Mental Illness in StateFunded Mental Health Centers. Psychiatr Serv. 2018 Jun 1;69(6):664-70. doi: 10.1176/appi.ps.201700368. Epub 2018 Apr 2. PMID: 29606077.

35. Naslund JA, Aschbrenner KA, Bartels SJ. Wearable devices and smartphones for activity tracking among people with serious mental illness. Ment Health Phys Act. 2016 Mar;10:10-17. doi: 10.1016/j.mhpa.2016.02.001. PMID: 27134654; PMCID: PMC4845759.

36. Magni LR, Ferrari C, Rossi G, Staffieri E, Uberti A, Lamonaca D, et al. Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugsBraz J Psychiatry. 2017 JulSep;39(3):244-251. doi: 10.1590/1516-4446-2016-1993. Epub 2017 Mar 13. PMID: 28300948; PMCID: PMC7111394.

37. Giusti L, Bianchini V, Aggio A, Mammarella S, Salza A, Necozione S, et al. Twelve-month outcomes in overweight/ obese users with mental disorders following a multielement treatment including diet, physical activity, and positive thinking: The real-world “An Apple a Day” controlled trial. Front Psychiatry. 2022 Aug 23;13:903759. doi: 10.3389/fpsyt.2022.903759. PMID: 36081460; PMCID: PMC9445251.

38. Ito H, Kumagai T, Iwama T. Evaluation of an educational wellness program by sex differences in community-dwelling Japanese patients with schizophrenia. Arch Psychiatr Nurs. 2021 Oct;35(5):450-6. doi: 10.1016/j.apnu.2021.06.005. Epub 2021 Jun 22. PMID: 34561058.

39. McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophr Bull. 2016 Jan;42(1):96-124. doi: 10.1093/schbul/sbv101. Epub 2015 Jul 28. PMID: 26221050; PMCID: PMC4681556.

40. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022 Aug;133:155217. doi: 10.1016/j.metabol.2022.155217. Epub 2022 May 15. PMID: 35584732; PMCID: PMC9107388.

41. Tremmel M, Gerdtham UG, Nilsson P, Saha S. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health. 2017 Apr 19;14(4):435. doi: 10.3390/ ijerph14040435. PMID: 28422077; PMCID: PMC5409636.

42. Organisation for Economic Co-operation and Development (OECD). The Heavy Burden of Obesity. OECD; 2019. Available from: https://www.oecd.org/en/publications/theheavy-burden-of-obesity_67450d67-en.html [Last accessed: 2025 Jan 4].

43. d’Errico M, Pavlova M, Spandonaro F. The economic burden of obesity in Italy: a cost-of-illness study. Eur J Health Econ. 2022 Mar 4;23(2):177-92. doi: 10.1007/s10198-021 -01358-1. Epub 2021 Aug 4. PMID: 34347176; PMCID: PMC8882110.

44. Burrows T, Teasdale S, Rocks T, Whatnall M, Schindlmayr J, Plain J, et al. Cost effectiveness of dietary interventions for individuals with mental disorders: A scoping review of experimental studies. Nutr Diet. 2022 Jul 12;79(3):291-302. doi: 10.1111/1747-0080.12703. Epub 2021 Sep 12. PMID: 34510689.

45. Libowitz MR, Nurmi EL. The Burden of AntipsychoticInduced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry. 2021 Mar 12;12:623681. doi: 10.3389/fpsyt.2021.623681. PMID: 33776816; PMCID: PMC7994286.

46. Briguglio M, Vitale J, Galentino R, Banfi G, Zanaboni Dina C, Bona A, et al. Healthy Eating, Physical Activity, and Sleep Hygiene (HEPAS) as the Winning Triad for Sustaining Physical and Mental Health in Patients at Risk for or with Neuropsychiatric Disorders: Considerations for Clinical Practice. Neuropsychiatr Dis Treat. 2020 Jan 8;16:55-70. doi: 10.2147/NDT.S229206. PMID: 32021199; PMCID: PMC6955623.

Downloads

Published

2025-02-13

Issue

Section

Original research

How to Cite

1.
Picardo G, Donnoli C, Liotta G. Lifestyle Interventions in Weight Loss Programs for Community- Based Patients with Severe Mental Disorders: A Scoping Review. Ann Ig. 2025;37(5):595-609. doi:10.7416/ai.2025.2689